iCAN science seminar on Reverse translation towards understanding biological heterogeneity of lymphomas with Prof. Jessica Okosun
Warm welcome to the iCAN science seminar, and to the public examination of Matias Autio with Prof. Jessica Okosun as the opponent on Fri, January 31!
Speaker: Jessica Okosun, Professor of Translational Cancer Research, MB BChir PhD,
Barts Cancer Institute, Queen Mary University of London
Talk title: Reverse translation towards understanding biological heterogeneity of lymphomas
When: Fri 31.1.2025 at 10:30-11:30
Where: Biomedicum 1, seminar room 3, and online
Zoom-link (Meeting ID: 648 0498 6682 Passcode: 366409)
Host: Prof. Sirpa Leppä
The defense will take place in Biomedicum 1, Lecture hall 2 at 13.15. The title of Matias Autio’s doctoral thesis is “Characterization and clinical impact of immune microenvironment in diffuse large B-cell lymphoma”.
Jessica Okosun is Professor of Translational Cancer Research at Barts Cancer Institute, Queen Mary University of London and a Consultant Haematologist at St Bartholomew’s Hospital. Dr Okosun received her medical degree from the University of Cambridge in 2004 and undertook her haematology specialty training in London. She received her PhD in 2015 from the lab of Professor Jude Fitzgibbon focused on genomic profiling of follicular lymphoma and was awarded the Royal College of Pathologists Specialty Research Medal for this work. She was a scholar of the ASH-EHA Translational Research Training in Haematology (TRTH) program and was awarded a Cancer Research UK Clinician Scientist Fellowship to establish her group in 2018. She leads a translational lymphoma research group in non-Hodgkin’s lymphoma, focussed on understanding biological heterogeneity and the development of disease- and treatment-biomarkers. She is currently Deputy Director of the Centre for Haemato-Oncology.
Professor Okosun is the translational science lead on a number of UK lymphoma clinical trials (PETReA, OPTIMATE, PRIZM+, REFRACT). She serves as a member of the UK Low and High Grade Lymphoma, Brain Lymphoma and Lymphoma Science subgroups. She has additional roles as Chair of the Barts Cancer Centre’s Patient and Public Involvement Research Advisory Group, Member of the Research Committee of the European Haematology Association (EHA), Member of the International Advisory Board for Lancet Haematology, serves on the editorial board of Blood Advances and is Associate Editor for eJHaem and Haematologica.
There will be coffee server prior to the seminar.
For more information on the science seminar series, please contact ican-comms@helsinki.fi